Symbol="CYCCP"
AssetType="Preferred Stock"
Name="Cyclacel Pharmaceuticals Inc"
Description="Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops drugs for the treatment of cancer and other proliferative diseases. The company is headquartered in Berkeley Heights, New Jersey."
CIK="1130166"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="200 CONNELL DRIVE, SUITE 1500, BERKELEY HEIGHTS, NJ, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="27666400"
EBITDA="-28385000"
PERatio="None"
PEGRatio="0"
BookValue="0.809"
DividendPerShare="0"
DividendYield="0.0392"
EPS="-2.047"
RevenuePerShareTTM="0.01"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.576"
ReturnOnEquityTTM="-1.051"
RevenueTTM="150000"
GrossProfitTTM="-455000"
DilutedEPSTTM="-2.047"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="-"
EVToRevenue="-"
EVToEBITDA="-"
Beta="1.059"
num_52WeekHigh="22.12"
num_52WeekLow="5.73"
num_50DayMovingAverage="12.16"
num_200DayMovingAverage="12.21"
SharesOutstanding="12497400"
DividendDate="2023-08-01"
ExDividendDate="2023-07-20"
symbol="CYCCP"
open="15.31"
high="15.31"
low="15.31"
price="15.31"
volume="1.00"
latest_trading_day="2023-07-28"
previous_close="15.31"
change="0.00"
change_percent="0.0000%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="52"
trend_strength="Strong Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="48"
Volume_recent_avg="2788"
Change_recent_avg="-0.06"
Delta_recent_avg="1.09"
Variance_recent_avg="0.55"
Change_ratio_recent_avg="-0.4"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="48"
Aroon_momentum_negative="52"
image_negative_thumbnail_id_1="102"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0074.jpeg"
image_negative_thumbnail_id_2="137"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0039.jpeg"
image_neutral_thumbnail_id_1="525"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0074.jpeg"
image_neutral_thumbnail_id_2="556"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0043.jpeg"
image_positive_thumbnail_id_1="659"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0049.jpeg"
image_positive_thumbnail_id_2="633"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0075.jpeg"
image_professor_thumbnail_id_1="1177"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
